Jean Pierre Garnier - Jun 5, 2025 Form 4 Insider Report for BioAge Labs, Inc. (BIOA)

Role: Director
Signature: /s/ Dov A. Goldstein as attorney-in-fact
Stock symbol: BIOA
Transactions as of: Jun 5, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/9/2025, 04:41 PM
Previous filing: Apr 11, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
GARNIER JEAN PIERRE	Director	C/O BIOAGE LABS, INC., 5885 HOLLIS STREET, SUITE 370, EMERYVILLE	/s/ Dov A. Goldstein as attorney-in-fact	2025-06-09	0001184175

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIOA	Stock Option (Right to Buy)	Award	$0	+22K		$0.00	22K	Jun 5, 2025	Common Stock	22K	$4.44	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The entire option award shall vest on the earlier of: (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the one year anniversary of the grant date, subject to the reporting person's continued service to the Issuer on the applicable vesting date.